Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements6003Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4910Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10934 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 6003

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Wellness & Workforce Solution for Lupus/Lupus Nephritis NCT06217107 · NCT06217107 Lupus À vérifier Non applicable RECRUITING The investigators will test the hypothesis that culturally congruent coach… À vérifier ClinicalTrials.gov 2026-08-16 21:21:41 Détail
Chemo Brain — Cognitive Impairment in Colorectal Cancer Patients Rece… NCT05014399 · NCT05014399 Cancer À vérifier À vérifier RECRUITING The purpose of this research study is to see how the brain changes in pati… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Convertible Plasma Jet NCT06222788 · Breast Cancer Plasma Adjuvant Intra-operative Treatment (Breast Cancer PAINT) Cancer Traitement symptomatique Non applicable RECRUITING The goal of this clinical trial is to test the safety of the use of non-th… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Expressive Writing for the Management of Stress in Cancer Survivors NCT04776941 · NCT04776941 Cancer Thérapie génique Non applicable RECRUITING This clinical trial evaluates the effect of expressive writing for the man… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Oxaliplatin, 5FU, leucovorin NCT07062536 · mFOLFOX/mFOLFIRI vs. mFOLFOX in Advanced or Recurrent Biliary Tract Cancer Secon… Cancer À vérifier Phase 2 RECRUITING In second line with advanced or recurrent biliary tract cancer refractory… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
PF-06821497 NCT06629779 · A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Ca… Cancer À vérifier Phase 3 RECRUITING This study will explore whether a combination of the investigational drug… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
PROMOTE — Gene Expression in Patients With Metastatic Prostate Cancer… NCT01953640 · NCT01953640 Cancer Thérapie génique À vérifier COMPLETED This research trial studies gene expression in patients with prostate canc… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Rilvegostomig NCT06627647 · A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for… Cancer Ralentissement de la progression Phase 3 RECRUITING DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd +… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Supra Inguinal Fascia Iliaca Block Versus Ultrasound-guided Caudal An… NCT07056946 · NCT07056946 Cancer À vérifier Non applicable COMPLETED patients will then be randomized in the two groups. 1. Group C: in this gr… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Telisotuzumab Adizutecan NCT06772623 · Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab… Cancer À vérifier Phase 1/2 RECRUITING Non small cell lung carcinoma (NSCLC) is the most frequently occurring his… À vérifier ClinicalTrials.gov 2026-08-16 21:21:36 Détail
Anti-CD40 Agonist Monoclonal Antibody CDX-1140 NCT05231122 · Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-11… Cancer Traitement symptomatique Phase 2 RECRUITING This phase II trial tests whether pembrolizumab combined with bevacizumab… À vérifier ClinicalTrials.gov 2026-08-16 21:21:35 Détail
Elranatamab NCT06152575 · MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P… Cancer Thérapie génique Phase 3 RECRUITING The purpose of this study is to learn about the study medicine called elra… À vérifier ClinicalTrials.gov 2026-08-16 21:21:35 Détail
flexible AIR coil NCT05043012 · Diagnostic Performance Of Non-Endorectal Coil Multiparametric Magnetic Resonance… Cancer À vérifier Non applicable RECRUITING Multiparametric MRI (mpMRI) of the prostate is an important tool for diagn… À vérifier ClinicalTrials.gov 2026-08-16 21:21:35 Détail
Hemanext ONE system NCT06685848 · Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion Cancer À vérifier Non applicable ACTIVE_NOT_RECRUITING The overall objective of this study is to collect preliminary effectivenes… À vérifier ClinicalTrials.gov 2026-08-16 21:21:35 Détail
PROACTION: — Investigations of Reproductive Cancers in Women NCT06527157 · NCT06527157 Cancer À vérifier À vérifier RECRUITING The goal of this study is to create a non-invasive diagnostic test to rule… À vérifier ClinicalTrials.gov 2026-08-16 21:21:35 Détail
HPV ctDNA Response based radiation NCT07425054 · CHART-AC — ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment i… Cancer À vérifier Phase 2 RECRUITING This study is for people who have anal cancer and have not yet had treatme… À vérifier ClinicalTrials.gov 2026-08-16 21:21:34 Détail
Hydrocortisone NCT07763210 · Lazarus: IT Therapy for ICANS Cancer Ralentissement de la progression · Thérapie génique Phase 2 NOT_YET_RECRUITING The purpose of this study is to assess the efficacy and safety of opevesos… À vérifier ClinicalTrials.gov 2026-08-16 21:21:34 Détail
IMPACT STREAM — Master Framework For Relapse or Refractory Acute Myel… NCT06459024 · NCT06459024 Cancer À vérifier À vérifier RECRUITING This is an observational (non-interventional), prospective, cohort study t… À vérifier ClinicalTrials.gov 2026-08-16 21:21:34 Détail
Post-operative radiotherapy NCT06878274 · RESCUE — Post-operative Radiotherapy After Neodjuvant Chemo-immunotherapy and Su… Cancer À vérifier Phase 2 RECRUITING This study investigates whether postoperative radiotherapy (PORT) improves… À vérifier ClinicalTrials.gov 2026-08-16 21:21:34 Détail
Tislelizumab NCT05758116 · Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiati… Cancer À vérifier Phase 2 COMPLETED The current standard of care for locally advanced non-small cell lung canc… À vérifier ClinicalTrials.gov 2026-08-16 21:21:34 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4910

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 Maladie rénale chronique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… Environmental toxicology and pharmacology 2026-11-15 04:38:02 Source
Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 Source
Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 Maladie rénale chronique À vérifier Publication PubMed Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 Source
Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 Cancer Immunomodulation Publication PubMed Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… Biomaterials 2026-11-15 04:37:50 Source
Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 Insuffisance cardiaque Neuroprotection · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… Bioactive materials 2026-11-15 04:37:50 Source
Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… DEN open 2026-11-15 04:37:50 Source
Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 Maladie coronarienne À vérifier Publication PubMed Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… DEN open 2026-11-15 04:37:45 Source
Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… International journal of cardiology 2026-11-15 04:37:45 Source
Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 Maladie coronarienne À vérifier Publication PubMed Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 Source
Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Thérapie cellulaire Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Annals of translational medicine 2026-11-15 04:37:41 Source
Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… Cartilage 2026-11-15 04:37:41 Source
Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 Insuffisance cardiaque À vérifier Publication PubMed Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 Source
Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 Myasthénie À vérifier Publication PubMed Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 Source
Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 Myasthénie À vérifier Publication PubMed Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… ACS omega 2026-11-15 04:37:34 Source
Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 Myopathies À vérifier Publication PubMed Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… The lancet. Psychiatry 2026-11-15 04:37:30 Source
Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 Myopathies À vérifier Publication PubMed Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 Source
Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 Myopathies Traitement symptomatique Publication PubMed Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 Source
Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 Cancer Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… Cancer immunology research 2026-11-15 04:37:24 Source
Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 Cancer Immunomodulation Publication PubMed Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… Journal of biological engineering 2026-11-15 04:37:24 Source
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 Lupus À vérifier Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Leukemia 2026-11-15 04:37:24 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.